You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Pelvic Prolapse1 Apr 2016MP10-14 LONG-TERM RESULTS OF CYSTOCELE REPAIR WITH SOLVENT-DEHYDRATED CADAVERIC FASCIA OR DERMAL ALLOGRAFT: 559 PATIENTS WITH 4-YEAR FOLLOW-UP Saad Juma, Sharon Mee, and Gary Leach Saad JumaSaad Juma More articles by this author , Sharon MeeSharon Mee More articles by this author , and Gary LeachGary Leach More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.2344AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES With increasing concerns regarding mesh complications, there has been renewed interest in cystocele repair with biologic graft augmentation. There are few studies reporting long-term outcomes of cystocele repair using biologic materials. Herein, we report long-term results of cystocele repair using either non-frozen, solvent-dehydrated (NFSD) cadaveric fascia (Suspend) or dermal allograft (AXIS). METHODS A retrospective analysis was performed on two prospectively maintained databases of women undergoing cystocele repair at two institutions. A total of 992 women underwent cystocele repair between 2000 and 2014. Mean patient age was 65.6 years (range 30 - 99). 559/992 (56.4%) of patients had ≥12 month follow-up by physical exam with mean and maximum follow up of 4 and 11.8 years. 645/992 (65.0%) of patients had ≥12 month follow-up by questionnaire with mean and maximum follow-up of 4.8 and 11.8 years. Pre-op cystocele grades were: G1 - 10 (1.8%), G2 - 121 (21.7%), G3 - 260 (46.5%), G4 - 168 (30.1%). RESULTS Recurrent cystocele (grade 2 or higher using the Baden-Walker system) was seen in 61/559 (10.9%). Prolapse recurrence in anterior and/or apical compartments occurred in 130/559 (23.3%) patients. At the time of last questionnaire, 388/461 (84.2%) patients would repeat surgery and 393/461 (85.2%) would recommend surgery. 71/461 (15.4%) patients were sexually active. Of these, 22 (31%) reported dyspareunia. Significant improvement was demonstrated comparing pre and post-op scores for all questionnaires: IIQ 11 vs. 3.8; UDI 9 vs. 3.8; VAS 2 vs. 5.8 (p<0.05 for all). Complications occurred in 27/559 (4.8%) patients. In the cadaveric fascia group, 24/375 (6.1%) patients had the following complications: 13 vaginal granulation tissue, 4 urinary retention, 2 wound separation, 1 vaginal suture exposure, 1 vaginal sling exposure, 1 infected vaginal hematoma, 1 transient ureteral obstruction, 1 SB injury during SPT placement. In the dermal allograft group, 3/184 (1.6%) patients had the following complications: 1 vaginal allograft exposure, 1 dyspareunia, 1 transient hydronephrosis. CONCLUSIONS With mean and maximum follow-up of 4 and 11.8 years, patients undergoing cystocele repair with either NFSD cadaveric fascia or dermal allograft have excellent and durable results. 76.7% of patients had no significant prolapse recurrence. There was high patient satisfaction and low morbidity. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e107 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Saad Juma More articles by this author Sharon Mee More articles by this author Gary Leach More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract